Hangzhou, China, July 4, 2024 /PRNewswire/ — Giant Biogene, the global leader in recombinant collagen[1] has announced the launch of its latest ultra-premium skincare line, Vpro, specially designed to address advanced anti-wrinkle, firming and lifting needs. Vpro combines Vlock 4D recombinant collagen with Bosein and polypeptides for comprehensive, multi-dimensional skin rejuvenation.
Known for pioneering research into recombinant collagen[1]Giant Biogene continues to lead the way in developing cutting-edge solutions to address complex challenges in the cosmetics industry. The company’s latest product line, VPro, incorporates the latest breakthrough Vlock 4D recombinant collagen, representing a remarkable advancement in collagen-based anti-aging treatments.
A recent study from Giant Biogene’s R&D facility outlines three main benefits of Vlock 4D recombinant collagen:
1. Replenish cellular energy and stimulate cellular vitality
ATP is essential for cell survival and serves as the cell’s energy center.r[2]The relative fluorescence intensity of mitochondrial membrane potential in human fibroblasts is 313.92% at the tested concentration of Vlock 4D recombinant collagen.[3].
2. Promotes the growth of nine types of collagen and various intercellular matrices
Analysis of Vlock 4D recombinant collagen raw material showed that compared with the control group, gene expression of collagen types I, III, IV, V, VI, VII, XIII, XVI, and XVII was enhanced, especially the gene expression of collagen type III was increased by 276.46%.[3]. Furthermore, recombinant collagen significantly promotes gene expression of filaggrin (FLG), loricrin (LOR), and the tight junction protein ZO-1.[3].
3. Achieves effective percutaneous absorption and rapid penetration into the dermis layer
Using Vlock 4D recombinant collagen as the test sample, the transdermal absorption test demonstrated successful penetration from the epidermis to the dermis after 8 hours and 24 hours. Supported by Giant Biogene’s patented transdermal absorption technology.[4]These results provide a strong basis for the percutaneous absorption of collagen.
Proven Results: Increased dermal density and enhanced collagen strength
A study of 31 subjects showed that after 4 consecutive weeks of use, products containing Vlock 4D recombinant collagen significantly increased dermal density compared to before use. Measurements taken after 15 minutes, 2 weeks, and 4 weeks showed continued improvement, with the increase in dermal density reaching 20.3% after 4 weeks, indicating a significant increase in collagen strength.[5]These experimental results validate the effectiveness of products containing Vlock 4D recombinant collagen.
|
1. Source: Euromonitor International (Shanghai) Limited, based on 2023 revenue. Recombinant collagen companies are defined as companies that can independently develop, produce and sell recombinant collagen raw materials, or that can produce and sell end products using their own recombinant collagen as the main raw material. Recombinant collagen is created using recombinant DNA technology, which involves genetic engineering and/or modification of the gene that codes for the required human collagen protein. The process involves using a plasmid or viral vector to introduce the target gene into a suitable host cell (such as bacteria, yeast, or other eukaryotic cells), which is then expressed and translated into collagen or collagen-like peptides. End products are prepared by extraction and purification and include recombinant human collagen, recombinant human-like collagen, and recombinant collagen-like proteins. Survey completed in March 2024. |
SOURCE Hangzhou Giant Biogene Technology Co., Ltd.
